Table 2.
Genes | Coefb | HRc | 95% CId | P‐value |
---|---|---|---|---|
SLCO2A1e | 1.5813 | 4.861 | 1.763–13.4 | 0.00225** |
CGNL1e | 0.9902 | 2.692 | 1.546–4.686 | 0.000464*** |
SUPV3L1f | 0.8437 | 2.325 | 1.168–4.629 | 0.0163* |
TATDN2f | 1.3132 | 3.718 | 1.855–7.45 | 0.000213*** |
MGAT4Bf | 1.5178 | 4.562 | 2.245–9.272 | 2.73e‐5*** |
VAV2f | 1.1027 | 3.012 | 1.671–5.429 | 0.000244*** |
SLC25A33f | 1.096 | 2.992 | 1.55–5.777 | 0.00109** |
MCCC1f | 0.8336 | 2.302 | 1.322–4.007 | 0.00321** |
ASNSf | 1.3456 | 3.84 | 2.064–7.145 | 2.15e‐5*** |
CASKIN1f | 1.0286 | 2.797 | 1.55–5.047 | 0.000636*** |
DNMT3Bf | 1.2919 | 3.64 | 1.928–6.87 | 6.73e‐5*** |
AURKAf | 1.0966 | 2.994 | 1.692–5.298 | 0.000166*** |
OIP5f | 1.365 | 3.914 | 2.022–7.576 | 5.13e‐5*** |
CTHRC1f | 0.7981 | 2.221 | 1.15–4.289 | 0.0174* |
GOLGA7Bf | 2.0406 | 7.695 | 2.388–24.79 | 0.00063*** |
Univariate Cox analysis was performed using the TCGA Provisional cohort (n = 492).
Cox coefficient.
Hazard ratio.
Confidence interval.
Gene expression was < −1.5 SD of the reference population mean.
Gene expression was at > 2 SD of the reference population mean.
*P < 0.05; **P < 0.01; ***P < 0.001.